可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Prabha M, Jin HF, Tian Y, et al. Mechanisms responsible for pulmonary hypertension[J]. Chin Med J (Engl), 2008, 121(24):2604-2609.
[2]Eddahibi S, Morrell N, DOrtho MP, et al. Pathobiology of pulmonary arterial hypertension[J]. Eur Respir J, 2002, 20(6):1559-1572.
[3]Dempsie Y, Maclean MR. Pulmonary hypertension: therapeutic targets within the serotonin system[J]. Br J Pharmacol, 2008, 155(4):455-462.
[4]Maclean MR, Dempsie Y. Serotonin and pulmonary hypertension-from bench to bedside?[J]. Curr Opin Pharmacol, 2009, 9(3):281-286.
[5]Keegan A, Morecroft I, Smillie D, et al. Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935[J]. Circ Res, 2001, 89(12):1231-1239.
[6]Pei JM, Sun X, Guo HT, et al. U50,488H depresses pulmonary pressure in rats subjected to chronic hypoxia[J]. J Cardiovasc Pharmacol, 2006, 47(4):594-598.
[7]孙新,苏慧,臧益民,等. U50488H对低氧性肺动脉高压大鼠体内一氧化氮、内皮素及血管紧张素II水平的影响[J]. 心脏杂志, 2007, 19(3):249-257.
[8]Maclean MR, Morecroft I. Increased contractile response to 5-hydroxytryptamine1-receptor stimulation in pulmonary arteries from chronic hypoxic rats: role of pharmacological synergy[J]. Br JPharmacol, 2001, 134(3):614-620.
[9]Wang HL, Dong X, Zhang XH, et al. 5-HT1B receptor augmented 5-HT vasoconstrictor response of pulmonary artery in monocrotaline-induced pulmonary hypertensive rats[J]. Acta Pharmacol Sin, 2001, 22(3):269-273.
[10]杨藻宸. 药理学和药物治疗学[M]. 北京: 人民卫生出版社, 2000:1321-1323.
[11] 王爽,王怀良. 5-HT1B受体介导的ERK MAPK信号转导通路与肺动脉高压的关系[M]// 苏宽冯,缪朝玉,王永铭. 药理学进展. 北京: 人民卫生出版社, 2004:129-135.